G. Casado

A CONSTRUÇÃO E PERDIÇÃO DA PERSONAGEM EM “O COMPANHEIRO DO GUARDIÃO” DE JOHN AJVIDE LINDQVIST

G. Casado

This article does an analysis about the main character construction on the fantastic short tale The Keeper’s Companion (2017) and its transformations occurred on the narrative process. Considering the constructive ways and character development after structuralist concepts, the article does one analyses …

AB1666 CLUSTER ANALYSIS TO IDENTIFY PATIENT GROUPS AND ASSESS THE PRESENCE OF ADVERSE EVENTS. REAL WORLD EVIDENCE FROM THE BIOBADASAR 3.0 REGISTRY

J. A. Brigante, Karen Roberts, C. A. Isnardi, G. Gómez et autres

ar (code pays fourni par la source)

POS0974 CARDIOVASCULAR OUTCOMES OF ANTI-TNF ALFA AND JAK INHIBITORS IN PATIENTS WITH RHEUMATOID AND PSORIATIC ARTHRITIS. REAL WORLD EVIDENCE AND INSIGHTS OF BIOBADASAR 3.0 REGISTRY

J. A. Brigante, Karen Roberts, C. A. Isnardi, G. Gómez et autres

ar (code pays fourni par la source)

Evaluation of belimumab treatment in patients with systemic lupus erythematosus in a clinical practice setting: Results from a 24-month OBSErve study in Argentina

Alejandra Babini, A Cappuccio, Cesar Caprarulo, G. Casado et autres

OBJECTIVE: To describe clinical effectiveness of belimumab for systemic lupus erythematosus (SLE) in real-world practice in Argentina. METHODS: This retrospective, observational study analysed medical record data of patients with SLE treated with belimumab in 15 centres in Argentina. Primary endpoint: overall clinical …

ar (code pays fourni par la source)

Sixth report of adverse events with biological treatments in Argentina. BIOBADASAR registry report

Gabriela Vilas Bôas Gomez, Guillermo Pons‐Estel, Gustavo Citera, Emilie Soriano et autres

Objective: update the results of the BIOBADASAR registry on safety, duration and causes of treatment interruption after 8 years of follow-up. Methods: BIOBADASAR is a safety record of biological therapies established by the Argentine Society of Rheumatology. The description of BIOBADASAR 3.0 …

THU0619 Prevalence of pneumococcal vaccination in rheumatologic patients with community acquired pneumonia. biobadasar registry

Alejandro Brigante, Alvaro J. Benitez, Osvaldo Cerda, Soledad Retamozo et autres

SAT0488 Tuberculosis in A Registry of Rheumatic Patients Treated with Biological Drugs

Nadia Raquel Benzaquén, M. Haye Salinas, Juan Pablo Pirola, Soledad Retamozo et autres

AB0442 Regional Patterns of Tocilizumab Use, Efficacy, and Safety in Patients with Rheumatoid Arthritis: Interim Results from a Multinational Observational Study

B. Haraoui, G. Casado, Elke Theander, László Czirják et autres

se, hu, au, ch, it (code pays fourni par la source)

FRI0300 Baseline Characteristics and Pattern of TOCILIZUMAB Use in Patients with Rheumatoid Arthritis: Interim Results from the Multinational, Observational ACT-UP Study

B. Haraoui, G. Casado, Elke Theander, L. Czirják et autres

se, hu, au, ch, it (code pays fourni par la source)

Étude transversale internationale de la prévalence des comorbidités dans la polyarthrite rhumatoïde (PR) et évaluation de leur suivi (COMORA study : COMOrbidities in Rheumatoid Arthritis)

Fausto Mistretta, Jules Ferlet, Martin Soubrier, Anna Antunez et autres

fr, ve, Maroc, us, it (code pays fourni par la source)

Tercer reporte de eventos adversos con tratamientos biológicos en Argentina

María Vega, Gandhy Ponce Gómez, G. Casado, C Battagliotti et autres

Introducción: BIOBADASAR ((Registro Argentino de Eventos Adversos con Tratamientos Biológicos en Reumatología) comenzó en agosto de 2010. La importancia de este registro es mostrar datos locales que, probablemente, puedan diferir de otros registros. El objetivo es comunicar los resultados del tercer reporte …

FRI0560 Argentinian register of biologics treatments (biobadasar). results

Verónica Saurit, María Celina De la Vega, Gustavo Citera, Erika Catay et autres

ar (code pays fourni par la source)